Emerson Q2 Results Validate Cautious Stance as Software Volatility and China Weakness Persist

What happened

Emerson's Q2 FY2026 results and updated outlook show continued software ACV growth and backlog conversion but also reinforce the renewal-timing volatility and China headwinds that have kept the stock in a wait-and-see pattern. The $0.555 quarterly dividend confirms capital return policy, yet the $9.2B RPO and ~75% conversion rate remain critical to monitor. Our analysis, based on Q1 filings, already flagged the ~2 point margin swing from renewal timing and Intelligent Devices' China decline, which the Q2 report does not resolve. The updated FY2026 outlook reiterates $6.40-$6.55 EPS and $3.5-$3.6B FCF, implying no deterioration but no acceleration to justify the 32x P/E. Until stable RPO and reduced renewal disruption are demonstrated, the WAIT rating with a $122 attractive entry remains appropriate.

Implication

The dividend provides a modest floor, but the premium 32x P/E leaves the stock vulnerable to any miss on software renewal timing or deeper China slowdown. The next two quarters are critical: if RPO holds above $9.2B and Software & Systems avoids another 2-point margin swing, the bull case ($165) could materialize. However, if China weakness persists or backlog conversion slows, the bear case ($110) becomes more likely. We recommend trimming on strength above $155 and considering adding near $122. The thesis is unchanged: wait for operational proof or a better entry.

Thesis delta

The Q2 update provides no material improvement over the Q1-based thesis; the same risks (software renewal volatility, China declines) and same cash return supports remain in place. The thesis delta is neutral: we still need two more quarters of clean execution to upgrade from WAIT.